Zentiva 2 Logo

Zentiva 2

European provider of high-quality, affordable generic and over-the-counter medicines.

SKF | BSSE

Overview

Corporate Details

ISIN(s):
SK1120004439
LEI:
549300QOMTN6WGO3VV78
Country:
Slovakia
Address:
Einsteinova 24, 85101 Bratislava
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Based on the provided sources, Zentiva is a European pharmaceutical company focused on developing, manufacturing, and marketing a wide range of generic and over-the-counter (OTC) medicines. The company's mission is to provide high-quality, affordable healthcare solutions across Europe and other regions. Zentiva actively participates in industry events such as CPHI Worldwide to foster innovation and partnerships. The company employs over 4,700 people and is committed to corporate social responsibility, including initiatives supporting gender equality.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Zentiva 2 filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Zentiva 2

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Zentiva 2 via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Develops DNA vaccines and therapeutics for companion animals and livestock.
South Korea 222670
Pluri Inc. Logo
Develops placenta-based cell therapeutics using a proprietary 3D cell-expansion platform.
Israel PLUR
A global supplier of generic APIs using AI to accelerate drug development.
South Korea 041910
Poltreg S.A. Logo
Pioneering T-regulatory cell therapies for autoimmune diseases like diabetes, MS, and ALS.
Poland PTG
PolyPeptide Group AG Logo
A global CDMO specializing in peptide and oligonucleotide APIs for pharma and biotech partners.
Switzerland PPGN
Develops sensitive point-of-care biomarker diagnostics for human and animal health.
South Korea 335810
A global CDEMO offering end-to-end solutions for antibody therapeutics and biologics.
South Korea 334970
Develops affordable biosimilars and novel antibody drugs for life-threatening diseases.
Singapore 950210
Develops protein-based immunotherapies for metabolic diseases, immune disorders, and cancer.
South Korea 296160
PROTEINA CO.,LTD. Logo
A biotech firm specializing in proteomics for drug discovery and diagnostics in oncology.
South Korea 468530

Talk to a Data Expert

Have a question? We'll get back to you promptly.